CBU
GILD icon

CIBC Bancorp USA’s Gilead Sciences GILD Stock Holding History

CIBC Bancorp USA’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$44.3M Buy
351,087
+33,066
+10% +$4.36M 0.05% 271
2026
Q1 		$44.3M Buy
+318,021
New +$44.5M 0.06% 244
2025
Q3 		$24.4M Buy
+219,986
New +$25M 0.13% 123

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

CIBC Bancorp USA's GILD Position: Q2 2026 in Review

CIBC Bancorp USA increased its Gilead Sciences (GILD) stake by 10% in Q2 2026, buying an estimated $4.36M and bringing the position to 351,087 shares worth $44.3M. The position accounts for 0.05% of the portfolio, ranked #271.

CIBC Bancorp USA first reported a position in GILD in Q3 2025 and has held it in 3 quarters since. 2,169 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • CIBC Bancorp USA held 351,087 shares of Gilead Sciences worth $44.3M as of Q2 2026.
  • CIBC Bancorp USA bought 33,066 Gilead Sciences shares in Q2 2026, an estimated $4.36M.
  • Gilead Sciences made up 0.05% of CIBC Bancorp USA's portfolio in Q2 2026, its #271 holding.
  • CIBC Bancorp USA first reported a position in Gilead Sciences in Q3 2025 and has held it in 3 quarters since.
  • 2,169 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.